$2.03
+0.05 (+2.53%)
Open$1.95
Previous Close$1.98
Day High$2.24
Day Low$1.93
52W High$4.34
52W Low$1.41
Volume—
Avg Volume468.4K
Market Cap74.64M
P/E Ratio—
EPS$-0.60
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,380.3% upside
Current
$2.03
$2.03
Target
$30.05
$30.05
$22.12
$30.05 avg
$38.96
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.43M | 10.74M | 10.31M |
| Net Income | -2,402,162 | -1,945,366 | -2,138,218 |
| Profit Margin | -21.0% | -18.1% | -20.7% |
| EBITDA | -3,961,862 | -3,629,854 | -3,514,676 |
| Free Cash Flow | -2,281,552 | -2,429,555 | -1,597,015 |
| Rev Growth | +22.4% | -6.0% | +21.1% |
| Debt/Equity | 1.10 | 1.30 | 1.15 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |